[
  {
    "ts": "2026-01-13T08:02:39+00:00",
    "headline": "Biogen CEO Says New Drugs Offset MS Decline, Eyes 2026 “Transformational Era” at JPMorgan Conference",
    "summary": "Biogen (NASDAQ:BIIB) CEO Chris Viehbacher told investors the company has worked to stabilize its business as its multiple sclerosis (MS) portfolio continues to decline, while building new growth drivers and reshaping its cost structure. Speaking in a JPMorgan session moderated by analyst Chris Schot",
    "url": "https://www.marketbeat.com/instant-alerts/biogen-ceo-says-new-drugs-offset-ms-decline-eyes-2026-transformational-era-at-jpmorgan-conference-2026-01-13/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "c530faa1-d9f1-320b-9981-0332b8a8c9ab",
      "content": {
        "id": "c530faa1-d9f1-320b-9981-0332b8a8c9ab",
        "contentType": "STORY",
        "title": "Biogen CEO Says New Drugs Offset MS Decline, Eyes 2026 “Transformational Era” at JPMorgan Conference",
        "description": "",
        "summary": "Biogen (NASDAQ:BIIB) CEO Chris Viehbacher told investors the company has worked to stabilize its business as its multiple sclerosis (MS) portfolio continues to decline, while building new growth drivers and reshaping its cost structure. Speaking in a JPMorgan session moderated by analyst Chris Schot",
        "pubDate": "2026-01-13T08:02:39Z",
        "displayTime": "2026-01-13T08:02:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/f6cb92b1ab1bc201dca4d0e2002bf5de",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Biogen logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_.adyKbwRRIZ45mLKmAUSg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/f6cb92b1ab1bc201dca4d0e2002bf5de.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6T8EpjLAYHJzuBQ89qxUSg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/f6cb92b1ab1bc201dca4d0e2002bf5de.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/biogen-ceo-says-new-drugs-offset-ms-decline-eyes-2026-transformational-era-at-jpmorgan-conference-2026-01-13/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biogen-ceo-says-drugs-offset-080239656.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]